NPY controls fear conditioning and fear extinction by combined action on Y 1 and Y 2 receptors

British Journal of Pharmacology

Volumn 166, Issue 4, 2012, Pages 1461-1473

  Verma, D ^a   Tasan, R O ^a   Herzog, H ^b   Sperk, G ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

fear conditioning; fear extinction; neuropeptide Y; NPY; Y 1 receptor; Y 2 receptor

Indexed keywords

NEUROPEPTIDE Y; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONDITIONED REFLEX; CONDITIONING; CONTROLLED STUDY; FEAR; GENE DELETION; GENE INACTIVATION; GENOTYPE; MALE; MOUSE; NEUROMODULATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REINFORCEMENT; STIMULUS RESPONSE;

ANIMALS; ANXIETY DISORDERS; BEHAVIOR, ANIMAL; CONDITIONING, CLASSICAL; DISCRIMINATION (PSYCHOLOGY); EXTINCTION, PSYCHOLOGICAL; FEAR; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUROPEPTIDE Y; RECEPTORS, NEUROPEPTIDE Y; SIGNAL TRANSDUCTION;

EID: 84861306262     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2012.01872.x     Document Type: Article

References (48)

1. Alexander SPH, Mathie A, Peters JA, (2011). Guide to Receptors and Channels (GRAC), 5th Edition. Br J Pharmacol 164 (Suppl. 1): S1-S324.
2. Bacchi F, Mathe AA, Jimenez P, Stasi L, Arban R, Gerrard P, et al,. (2006). Anxiolytic-like effect of the selective neuropeptide Y Y2 receptor antagonist BIIE0246 in the elevated plus-maze. Peptides 27: 3202-3207.
3. Bannon AW, Seda J, Carmouche M, Francis JM, Norman MH, Karbon B, et al,. (2000). Behavioral characterization of neuropeptide Y knockout mice. Brain Res 868: 79-87.
4. Biedenkapp JC, Rudy JW, (2007). Context preexposure prevents forgetting of a contextual fear memory: implication for regional changes in brain activation patterns associated with recent and remote memory tests. Learn Mem 14: 200-203.
5. Broqua P, Wettstein JG, Rocher MN, Gauthier-Martin B, Junien JL, (1995). Behavioral effects of neuropeptide Y receptor agonists in the elevated plus-maze and fear-potentiated startle procedures. Behav Pharmacol 6: 215-222.
6. Colmers WF, Klapstein GJ, Fournier AS, Pierre S, Treherne KA, (1991). Presynaptic inhibition by neuropeptide Y in rat hippocampal slice in vitro is mediated by a Y2 receptor. Br J Pharmacol 102: 41-44.
7. Committee for the Update of the Guide for the Care and Use of Laboratory Animals, Council NR (2010). Guide for the Care and Use of Laboratory Animals, 8th edition. The National Academies Press: Washington, DC, p. 248.
8. Dumont Y, Fournier AS, Pierre S, Quirion R, (1993). Comparative characterization and autoradiographic distribution of neuropeptide Y receptor subtypes in the rat brain. J Neurosci 13: 73-86.
9. El Bahh B, Balosso S, Hamilton T, Herzog H, Beck-Sickinger AG, Sperk G, et al,. (2005). The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors. Eur J Neurosci 22: 1417-1430.
10. Fendt M, Burki H, Imobersteg S, Lingenhohl K, McAllister KH, Orain D, et al,. (2009). Fear-reducing effects of intra-amygdala neuropeptide Y infusion in animal models of conditioned fear: an NPY Y1 receptor independent effect. Psychopharmacology (Berl) 206: 291-301.
11. Giesbrecht CJ, Mackay JP, Silveira HB, Urban JH, Colmers WF, (2010). Countervailing modulation of Ih by neuropeptide Y and corticotrophin-releasing factor in basolateral amygdala as a possible mechanism for their effects on stress-related behaviours. J Neurosci 30: 16970-16982.
12. Gobbi M, Gariboldi M, Piwko C, Hoyer D, Sperk G, Vezzani A, (1998). Distinct changes in peptide YY binding to, and mRNA levels of, Y1 and Y2 receptors in the rat hippocampus associated with kindling epileptogenesis. J Neurochem 70: 1615-1622.
13. Gustafson EL, Card JP, Moore RY, (1986). Neuropeptide Y localization in the rat amygdaloid complex. J Comp Neurol 251: 349-362.
14. Gutman AR, Yang Y, Ressler KJ, Davis M, (2008). The role of neuropeptide Y in the expression and extinction of fear-potentiated startle. J Neurosci 28: 12682-12690.
15. Heilig M, (1995). Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding. Regul Pept 59: 201-205.
16. Heilig M, (2004). The NPY system in stress, anxiety and depression. Neuropeptides 38: 213-224.
17. Heilig M, McLeod S, Brot M, Heinrichs SC, Menzaghi F, Koob GF, et al,. (1993). Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects. Neuropsychopharmacology 8: 357-363.
18. Hitchcock JM, Davis M, (1987). Fear-potentiated startle using an auditory conditioned stimulus: effect of lesions of the amygdala. Physiol Behav 39: 403-408.
19. Hitchcock JM, Davis M, (1991). Efferent pathway of the amygdala involved in conditioned fear as measured with the fear-potentiated startle paradigm. Behav Neurosci 105: 826-842.
20. Karl T, Duffy L, Herzog H, (2008). Behavioural profile of a new mouse model for NPY deficiency. Eur J Neurosci 28: 173-180.
21. Karlsson RM, Choe JS, Cameron HA, Thorsell A, Crawley JN, Holmes A, et al,. (2007). The neuropeptide Y Y1 receptor subtype is necessary for the anxiolytic-like effects of neuropeptide Y, but not the antidepressant-like effects of fluoxetine, in mice. Psychopharmacology (Berl) 195: 547-557.
22. Kask A, Harro J, von Horsten S, Redrobe JP, Dumont Y, Quirion R, (2002). The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. Neurosci Biobehav Rev 26: 259-283.
23. Kopp J, Xu ZQ, Zhang X, Pedrazzini T, Herzog H, Kresse A, et al,. (2002). Expression of the neuropeptide Y Y1 receptor in the CNS of rat and of wild-type and Y1 receptor knock-out mice. Focus on immunohistochemical localization. Neuroscience 111: 443-532.
24. LeDoux JE, (2000). Emotion circuits in the brain. Annu Rev Neurosci 23: 155-184.
25. LeDoux JE, Iwata J, Cicchetti P, Reis DJ, (1988). Different projections of the central amygdaloid nucleus mediate autonomic and behavioural correlates of conditioned fear. J Neurosci 8: 2517-2529.
26. McDonald AJ, Pearson JC, (1989). Coexistence of GABA and peptide immunoreactivity in non-pyramidal neurons of the basolateral amygdala. Neurosci Lett 100: 53-58.
27. Nakajima M, Inui A, Asakawa A, Momose K, Ueno N, Teranishi A, et al,. (1998). Neuropeptide Y produces anxiety via Y2-type receptors. Peptides 19: 359-363.
28. Pape HC, Pare D, (2010). Plastic synaptic networks of the amygdala for the acquisition, expression, and extinction of conditioned fear. Physiol Rev 90: 419-463.
29. Redrobe JP, Dumont Y, Herzog H, Quirion R, (2003). Neuropeptide Y (NPY) Y2 receptors mediate behaviour in two animal models of anxiety: evidence from Y2 receptor knockout mice. Behav Brain Res 141: 251-255.
30. Sainsbury A, Schwarzer C, Couzens M, Fetissov S, Furtinger S, Jenkins A, et al,. (2002a). Important role of hypothalamic Y2 receptors in body weight regulation revealed in conditional knockout mice. Proc Natl Acad Sci U S A 99: 8938-8943.
31. Sainsbury A, Schwarzer C, Couzens M, Jenkins A, Oakes SR, Ormandy CJ, et al,. (2002b). Y4 receptor knockout rescues fertility in ob/ob mice. Genes Dev 16: 1077-1088.
32. Sajdyk TJ, Schober DA, Smiley DL, Gehlert DR, (2002). Neuropeptide Y-Y2 receptors mediate anxiety in the amygdala. Pharmacol Biochem Behav 71: 419-423.
33. Schwenk F, Baron U, Rajewsky K, (1995). A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res 23: 5080-5081.
34. Sorensen AT, Kanter-Schlifke I, Carli M, Balducci C, Noe F, During MJ, et al,. (2008). NPY gene transfer in the hippocampus attenuates synaptic plasticity and learning. Hippocampus 18: 564-574.
35. Sorensen AT, Nikitidou L, Ledri M, Lin EJ, During MJ, Kanter-Schlifke I, et al,. (2009). Hippocampal NPY gene transfer attenuates seizures without affecting epilepsy-induced impairment of LTP. Exp Neurol 215: 328-333.
36. Stanic D, Brumovsky P, Fetissov S, Shuster S, Herzog H, Hokfelt T, (2006). Characterization of neuropeptide Y2 receptor protein expression in the mouse brain. I. Distribution in cell bodies and nerve terminals. J Comp Neurol 499: 357-390.
37. Stanic D, Mulder J, Watanabe M, Hokfelt T, (2011). Characterization of NPY Y2 receptor protein expression in the mouse brain. II. Coexistence with NPY, the Y1 receptor, and other neurotransmitter-related molecules. J Comp Neurol 519: 1219-1257.
38. Tasan RO, Lin S, Hetzenauer A, Singewald N, Herzog H, Sperk G, (2009). Increased novelty-induced motor activity and reduced depression-like behavior in neuropeptide Y (NPY)-Y4 receptor knockout mice. Neuroscience 158: 1717-1730.
39. Tasan RO, Nguyen NK, Weger S, Sartori SB, Singewald N, Heilbronn R, et al,. (2010). The central and basolateral amygdala are critical sites of neuropeptide Y/Y2 receptor-mediated regulation of anxiety and depression. J Neurosci 30: 6282-6290.
40. Tatemoto K, Carlquist M, Mutt V, (1982). Neuropeptide Y-a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 296: 659-660.
41. Tschenett A, Singewald N, Carli M, Balducci C, Salchner P, Vezzani A, et al,. (2003). Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors. Eur J Neurosci 18: 143-148.
42. Walker DL, Davis M, (1997). Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear. J Neurosci 17: 9375-9383.
43. Walker DL, Toufexis DJ, Davis M, (2003). Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety. Eur J Pharmacol 463: 199-216.
44. Wang SH, Teixeira CM, Wheeler AL, Frankland PW, (2009). The precision of remote context memories does not require the hippocampus. Nat Neurosci 12: 253-255.
45. Wiltgen BJ, Silva AJ, (2007). Memory for context becomes less specific with time. Learn Mem 14: 313-317.
46. Wittchen HU, Jacobi F, (2005). Size and burden of mental disorders in Europe-a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol 15: 357-376.
47. Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jonsson B, et al,. (2011). The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 21: 655-679.
48. Wolak ML, DeJoseph MR, Cator AD, Mokashi AS, Brownfield MS, Urban JH, (2003). Comparative distribution of neuropeptide Y Y1 and Y5 receptors in the rat brain by using immunohistochemistry. J Comp Neurol 464: 285-311.